BridgeBio Pharma Inc
Biotechnology
Healthcare
BBIO
189 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
29.63
52 week high
37.59
high
33.28
52 week low
22.35
previous Close
30.14
P/E ratio
market cap
5.25 B
div yield
0
net incoming
-162.04 M
-120.59 %
net profit margin
-5931.19 %
-25.43 %
operating incoming
-191.75 M
-9.23 %
net change in cash
-141.63 M
-296.67 %
cash on hand
266 M
-34.72 %
cost of revenue
598 K
0.00 %
top